PPP1R1C and glioblastoma: Our in situ analysis and subsequent experiments revealed that protein phosphatase 1 regulatory inhibitor subunit 1C (PPP1R1C) is a target of miR-182 in GBM and up regulation of PPP1R1C in GBM patients is partially responsible for observed resistance to temozolomide (TMZ) susceptibility.